StockData
OrthoPediatrics Corp logo

OrthoPediatrics Corp (KIDS) stock

KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/308% below fair value
$31.65+0.24 (+0.76%)

Close on Nov 18, 2026Market cap $826.40MP/E –Yield –

Earnings

OrthoPediatrics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 25, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$72.70M
+18.8% on a year earlier
Loss per share, diluted (non-GAAP), Q3 FY2026
-$0.23
-$0.24 a year earlier
Latest guidance
Raised
Oct 27, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of OrthoPediatrics's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 25, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 27, 2026after the close$72.70M+18.8%-$0.25-$0.23Release
Q2 FY2026ended Jun 30, 2026Aug 4, 2026during market hours$70.50M+15.4%-$0.30–Release
Q1 FY2026ended Mar 31, 2026Apr 30, 2026during market hours$59.40M+13.4%-$0.45-$0.42Release
Q4 FY2025ended Dec 31, 2025Feb 26, 2026during market hours$61.60M+16.9%-$0.43-$0.26Release
Q3 FY2025ended Sep 30, 2025Oct 28, 2025during market hours$61.20M+12.1%-$0.50-$0.24Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025during market hours$61.10M+15.7%-$0.30-$0.11Release
Q1 FY2025ended Mar 31, 2025May 7, 2025during market hours$52.40M+17.2%-$0.46-$0.39Release
Q4 FY2024ended Dec 31, 2024Mar 4, 2025during market hours$52.70M+40.2%-$0.69-$0.29Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024during market hours$54.60M+36.5%-$0.34-$0.18Release
Q2 FY2024ended Jun 30, 2024Aug 5, 2024during market hours$52.80M+33.3%-$0.26-$0.23Release
Q1 FY2024ended Mar 31, 2024May 6, 2024during market hours$44.70M+41.5%-$0.34-$0.30Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

OrthoPediatrics's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
growth over 2025 revenueFY2026+12% – +14%+11% – +13%RaisedAug 4, 2026
revenue guidanceFY2026$270.00M – $273.00M$262.00M – $266.00MRaisedOct 27, 2026
revenue guidanceFY2026$265.00M – $269.00M$263.00M – $267.00MRaisedAug 4, 2026
adjusted EBITDAnon-GAAPFY2026$25.00M$25.00MReaffirmedOct 27, 2026
adjusted EBITDAnon-GAAPFY2026$25.00M$25.00MReaffirmedAug 4, 2026
annual set deploymentFY2026$10.00M–NewAug 4, 2026
annual set deploymentFY2026$10.00M–NewFeb 26, 2026
annual set deploymentFY2026$10.00M–NewOct 27, 2026
annual set deploymentFY2026$10.00M–NewApr 30, 2026

Guidance vs results

The last range OrthoPediatrics gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$233.50M – $234.50M$236.30MΣ4QAbove range
FY2025Revenue growth+14% – +15%+15.38%Σ4QAbove range

Guidance history

Every forecast OrthoPediatrics put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 27, 2026adjusted EBITDAFY2026$25.00MReaffirmed
Oct 27, 2026annual set deploymentFY2026$10.00MNew
Oct 27, 2026revenue guidanceFY2026$270.00M – $273.00MRaised
Aug 4, 2026annual set deploymentFY2026$10.00MNew
Aug 4, 2026adjusted EBITDAFY2026$25.00MReaffirmed
Aug 4, 2026growth over 2025 revenueFY2026+12% – +14%Raised
Aug 4, 2026revenue guidanceFY2026$265.00M – $269.00MRaised
Apr 30, 2026adjusted EBITDAFY2026$25.00MReaffirmed
Apr 30, 2026annual set deploymentFY2026$10.00MNew
Apr 30, 2026growth over 2025 revenueFY2026+11% – +13%Reaffirmed
Apr 30, 2026revenue guidanceFY2026$263.00M – $267.00MRaised
Feb 26, 2026annual set deploymentFY2026$10.00MNew
Feb 26, 2026adjusted EBITDAFY2026$25.00MNew
Feb 26, 2026revenueFY2026$262.00M – $266.00MNew
Jan 12, 2026Adjusted EBITDAFY2026$25.00MNew
Jan 12, 2026revenue growthFY2026+11% – +13%New
Jan 12, 2026revenueFY2026$262.00M – $266.00MNew
Oct 28, 2025adjusted EBITDAFY2025$15.00M – $17.00MReaffirmed
Oct 28, 2025annual set deploymentFY2025$15.00MReaffirmed
Oct 28, 2025revenueFY2025$233.50M – $234.50MLowered

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases OrthoPediatrics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Results
  3. Update
  4. Results
  5. Update
  6. Results
  7. Update
  8. Results
  9. Update
  10. Results
  11. Update
  12. Results
  13. Results
  14. Update
  15. Results

See a number that looks wrong?